ESTRELLA IMMUNOPHARMA, INC. Preferred Stock, Dividend Rate, Percentage
ESTRELLA IMMUNOPHARMA, INC. (ESLA) reported Preferred Stock, Dividend Rate, Percentage of 8.00% for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockDividendRatePercentage · last filed 2025-11-12
- ESTRELLA IMMUNOPHARMA, INC. preferred stock, dividend rate, percentage for the quarter ending 2025-03-31 was 8.00%.
- ESTRELLA IMMUNOPHARMA, INC. preferred stock, dividend rate, percentage for the quarter ending 2024-09-30 was 8.00%, a 0.00% change year-over-year.
- ESTRELLA IMMUNOPHARMA, INC. preferred stock, dividend rate, percentage for the quarter ending 2023-09-30 was 8.00%.
- ESTRELLA IMMUNOPHARMA, INC. preferred stock, dividend rate, percentage for fiscal 2024 was 8.00%.
| Period end | Preferred Stock, Dividend Rate, Percentage 3 month | Preferred Stock, Dividend Rate, Percentage 6 month | Preferred Stock, Dividend Rate, Percentage 9 month | Preferred Stock, Dividend Rate, Percentage 12 month |
|---|---|---|---|---|
| 2025-09-30 | 8.00% 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | 8.00% 10-Q · filed 2025-08-12 | |||
| 2025-03-31 | 8.00% 10-Q · filed 2025-05-14 | |||
| 2024-12-31 | 8.00% 10-KT · filed 2025-03-25 | |||
| 2024-09-30 | 8.00% 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | 8.00% 10-K · filed 2024-09-27 | |||
| 2024-03-31 | 8.00% 10-Q · filed 2024-05-15 | |||
| 2023-12-31 | 8.00% 10-Q · filed 2024-02-14 | |||
| 2023-09-30 | 8.00% 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |